Mutations in STK11, KEAP1, and SMARCA4 predispose to inferior immune checkpoint inhibitor (ICI) efficacy in non-small cell lung cancer (NSCLC), particularly among KRAS-mutant cases. However, the frequency, clinicopathologic features, and clinical impact of deletions in these genes are poorly characterized.
Dr. Amer Zeidan presents interim Phase 1a results from the KOMET-007 trial, demonstrating the safety and robust clinical activity of ziftomenib combined with intensive chemotherapy…
Hello, My name is Elias Hanna. I am a student at Saint Ignatius High School in Cleveland, with a deep desire to make a…
Arguments have long raged about what role the private sector should play in the UK’s health system, where provision is dominated by the National Health…
Andreas Charalambous: Highlighting the importance of national cancer plans with ELLOK / Andreas Charalambous, cancer, ELLOC, European Cancer Organisation,
Recent advances in acute myeloid leukemia (AML) come from studies investigating younger (age<60 years) adults or older (age≥75 years) or less fit adults
The ability to diagnose MI was better with troponin I, but T better predicted mortality. Both tests have strengths, researchers say.
Jan 27, 2025 – News – In 2023, the U.S. federal government spent a staggering $1.5 trillion on healthcare, yet Americans are becoming unhealthier by…
It used to be that if we wanted to assess a patient’s back pain, we would evaluate how far the patient could bend by measuring…
Key pointsForty-one percent of referrals in the community were unable to access anti-CD19+ CARTs for NHL between 2018 and 2022.Attrition from disease-relat
In this issue of Blood Advances, Zandaki et al1 validated that the endothelial activation and stress index (EASIX) and modified EASIX (m-EASIX) scores pred
